HotHouse Therapeutics

📍 Norwich, United Kingdom👥 12 employees💰 Last funded Sep 2024
Biotechnology Research
LinkedIn
HotHouse Therapeutics is rewriting the future of drug discovery with BotanAI and BotanBio - our AI and plant bioengineering platforms that design and make molecules labs can’t reach. By transforming plants into sustainable biofactories, we unlock vast new chemical space, creating next-generation vaccine adjuvants and breakthrough therapeutics in days, not years. The urgency is clear: 62% of today’s medicines are natural or nature-inspired, yet conventional chemistry is slow, expensive, and environmentally harmful. As a sustainable biotech, our approach is different. Because our medicines grow in plants, they scale through vertical farming, are carbon-positive by design, and avoid destructive extraction. With deep expertise in plant science, chemistry, and AI, we’re building not just a pipeline, but a platform - delivering next-generation medicines that are greener, faster, and smarter.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in HotHouse Therapeutics?
HotHouse Therapeutics has 2 investors on record on gritt.io.
When did HotHouse Therapeutics last raise funding?
The most recent investment in HotHouse Therapeutics recorded on gritt.io was in September 2024.
What industry is HotHouse Therapeutics in?
HotHouse Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HotHouse Therapeutics based?
HotHouse Therapeutics is headquartered in Norwich, United Kingdom.